Twitter/X
LinkedIn

Food Technology - Fish-Free Seafood

  • Used the BREW Method to re-align R&D with business goals
  1. Discontinued 3 Lines of Effort (LOEs) that were not aligned
  2. Pivoted 2 LOEs to align better with product requirements
  3. Filled Resource gaps with external partners (CROs)
  4. Delivered critical technical unlocks for manufacturing
  5. Achieved self-GRAS declaration in 3 months
  • Successful product launch in Chicago Michelin Star Restaurant in 10 months

Food Technology/Precision Fermentation

  • Delivered engineered strains and bioprocesses for production of human breast milk glycoproteins​
  • Fundraising: secured $4MM in an oversubscribed seed round and $20MM in Series A financing
  • Established a platform to produce palm oil in oleaginous yeast

Microbiome Therapeutics

  • Designed a cGMP-compliant cleanroom facility for manufacture of skin probiotics
  • Scaled fermentation from bench to 5L and 50L leading to successful market testing and eventual acquisition by Crown Laboratories

Biofuels/Industrial Microbiology - BREW Success

  • ​Balancing:
  1. ​Established Line of Effort (LOE) to validate new unit ops for commercial plant at bench scale
  2. Pivoted strain engineering LOEs to align with commercial goals
  3. Discontinued a process engineering LOE that was not aligned and a deep cost
  • Resourcing:
  1. Raised new funding
  2. Hired new personnel to fill gaps
  3. Built an internal Multi-omics platform to reduce long turn around times with CROs
  • Execution:
  1. Created timelines with clearly defined milestones (KPIs) and deliverables (strains, PFD)
  2. Established regular operational reviews to ensure projects were on-track
  • Wins!
  1. ​Celebrated hitting critical titer and productivity KPIs
  2. Achieved GRAS certification for single-cell protein
  3. Signed a $20MM joint development agreement with a South Korean Company
Facebook

AgTech/Crop Protection

  • Delivered 10% improved strain/process for Spinosad using an improved high throughput screening platform.
  • Delivered 20% improved strain for Spinetoram using a novel genetic engineering approach.
  • Achieved approval for Inatreq® precursor (UK-2A). Performed risk reviews, improved strains and processes.
  • Commissioned and Qualified two ISO-6/7 cleanrooms.
  • Received approval for development of a novel “green” biosurfactant (soap).

We "BREW" success

Medical Device (IVD) Development

  • Led the development of a rapid (<10 minute) multi-plex real-time PCR diagnostic device, instrument and assay, from concept to 510k readiness including all DHF documentations (FMEAs, PRA, URRA, PRD, MRD, etc.)
  •  Led Verification and Flex testing for device and consumable.
  • Delivered novel DNA/RNA collection, extraction and preservation techniques.
  • Authored a patent on a novel cell-lysis product for gram+ and fungal pathogens.